Large diameter hemicraniectomy does not improve long-term outcome in malignant infarction
© 2023. The Author(s)..
INTRODUCTION: In malignant cerebral infarction decompressive hemicraniectomy has demonstrated beneficial effects, but the optimum size of hemicraniectomy is still a matter of debate. Some surgeons prefer a large-sized hemicraniectomy with a diameter of more than 14 cm (HC > 14). We investigated whether this approach is associated with reduced mortality and an improved long-term functional outcome compared to a standard hemicraniectomy with a diameter of less than 14 cm (HC ≤ 14).
METHODS: Patients from the DESTINY (DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY) registry who received hemicraniectomy were dichotomized according to the hemicraniectomy diameter (HC ≤ 14 cm vs. HC > 14 cm). The primary outcome was modified Rankin scale (mRS) score ≤ 4 after 12 months. Secondary outcomes were in-hospital mortality, mRS ≤ 3 and mortality after 12 months, and the rate of hemicraniectomy-related complications. The diameter of the hemicraniectomy was examined as an independent predictor of functional outcome in multivariable analyses.
RESULTS: Among 130 patients (32.3% female, mean (SD) age 55 (11) years), the mean hemicraniectomy diameter was 13.6 cm. 42 patients (32.3%) had HC > 14. There were no significant differences in the primary outcome and mortality by size of hemicraniectomy. Rate of complications did not differ (HC ≤ 14 27.6% vs. HC > 14 36.6%, p = 0.302). Age and infarct volume but not hemicraniectomy diameter were associated with outcome in multivariable analyses.
CONCLUSION: In this post-hoc analysis, large hemicraniectomy was not associated with an improved outcome or lower mortality in unselected patients with malignant middle cerebral artery infarction. Randomized trials should further examine whether individual patients could benefit from a large-sized hemicraniectomy.
CLINICAL TRIAL REGISTRATION INFORMATION: German Clinical Trials Register (URL: https://www.drks.de ; Unique Identifier: DRKS00000624).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:270 |
|---|---|
| Enthalten in: |
Journal of neurology - 270(2023), 8 vom: 10. Aug., Seite 4080-4089 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lehrieder, Dominik [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical Trial |
|---|
| Anmerkungen: |
Date Completed 20.07.2023 Date Revised 20.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00415-023-11766-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356654990 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356654990 | ||
| 003 | DE-627 | ||
| 005 | 20231226070924.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00415-023-11766-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356654990 | ||
| 035 | |a (NLM)37162579 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lehrieder, Dominik |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Large diameter hemicraniectomy does not improve long-term outcome in malignant infarction |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.07.2023 | ||
| 500 | |a Date Revised 20.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a INTRODUCTION: In malignant cerebral infarction decompressive hemicraniectomy has demonstrated beneficial effects, but the optimum size of hemicraniectomy is still a matter of debate. Some surgeons prefer a large-sized hemicraniectomy with a diameter of more than 14 cm (HC > 14). We investigated whether this approach is associated with reduced mortality and an improved long-term functional outcome compared to a standard hemicraniectomy with a diameter of less than 14 cm (HC ≤ 14) | ||
| 520 | |a METHODS: Patients from the DESTINY (DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY) registry who received hemicraniectomy were dichotomized according to the hemicraniectomy diameter (HC ≤ 14 cm vs. HC > 14 cm). The primary outcome was modified Rankin scale (mRS) score ≤ 4 after 12 months. Secondary outcomes were in-hospital mortality, mRS ≤ 3 and mortality after 12 months, and the rate of hemicraniectomy-related complications. The diameter of the hemicraniectomy was examined as an independent predictor of functional outcome in multivariable analyses | ||
| 520 | |a RESULTS: Among 130 patients (32.3% female, mean (SD) age 55 (11) years), the mean hemicraniectomy diameter was 13.6 cm. 42 patients (32.3%) had HC > 14. There were no significant differences in the primary outcome and mortality by size of hemicraniectomy. Rate of complications did not differ (HC ≤ 14 27.6% vs. HC > 14 36.6%, p = 0.302). Age and infarct volume but not hemicraniectomy diameter were associated with outcome in multivariable analyses | ||
| 520 | |a CONCLUSION: In this post-hoc analysis, large hemicraniectomy was not associated with an improved outcome or lower mortality in unselected patients with malignant middle cerebral artery infarction. Randomized trials should further examine whether individual patients could benefit from a large-sized hemicraniectomy | ||
| 520 | |a CLINICAL TRIAL REGISTRATION INFORMATION: German Clinical Trials Register (URL: https://www.drks.de ; Unique Identifier: DRKS00000624) | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Functional outcome | |
| 650 | 4 | |a Hemicraniectomy | |
| 650 | 4 | |a Malignant stroke | |
| 650 | 4 | |a Middle cerebral artery infarction | |
| 650 | 4 | |a Size of hemicraniectomy | |
| 700 | 1 | |a Müller, Hans-Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Kassubek, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Hecht, Nils |e verfasserin |4 aut | |
| 700 | 1 | |a Thomalla, Götz |e verfasserin |4 aut | |
| 700 | 1 | |a Michalski, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Gattringer, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Wartenberg, Katja E |e verfasserin |4 aut | |
| 700 | 1 | |a Schultze-Amberger, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Huttner, Hagen |e verfasserin |4 aut | |
| 700 | 1 | |a Kuramatsu, Joji B |e verfasserin |4 aut | |
| 700 | 1 | |a Wunderlich, Silke |e verfasserin |4 aut | |
| 700 | 1 | |a Steiner, Hans-Herbert |e verfasserin |4 aut | |
| 700 | 1 | |a Weissenborn, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Heck, Suzette |e verfasserin |4 aut | |
| 700 | 1 | |a Günther, Albrecht |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Hauke |e verfasserin |4 aut | |
| 700 | 1 | |a Poli, Sven |e verfasserin |4 aut | |
| 700 | 1 | |a Dohmen, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Woitzik, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Jüttler, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Neugebauer, Hermann |e verfasserin |4 aut | |
| 700 | 0 | |a DESTINY-R (DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry) Study Group and IGNITE (Initiative of German NeuroIntensive Trial Engagement) Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurology |d 1974 |g 270(2023), 8 vom: 10. Aug., Seite 4080-4089 |w (DE-627)NLM000508543 |x 1432-1459 |7 nnns |
| 773 | 1 | 8 | |g volume:270 |g year:2023 |g number:8 |g day:10 |g month:08 |g pages:4080-4089 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00415-023-11766-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 270 |j 2023 |e 8 |b 10 |c 08 |h 4080-4089 | ||